vs
ALPHA & OMEGA SEMICONDUCTOR Ltd（AOSL）与Apellis Pharmaceuticals, Inc.（APLS）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是ALPHA & OMEGA SEMICONDUCTOR Ltd的1.2倍（$199.9M vs $162.3M），ALPHA & OMEGA SEMICONDUCTOR Ltd净利率更高（-8.2% vs -29.5%，领先21.3%），Apellis Pharmaceuticals, Inc.同比增速更快（-5.9% vs -6.3%），Apellis Pharmaceuticals, Inc.自由现金流更多（$-14.3M vs $-23.1M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs 4.0%）
Alpha & Omega Semiconductor是一家专业功率半导体供应商，主营功率MOSFET、IGBT、模拟芯片及电源管理模块的研发、生产与销售，产品广泛应用于消费电子、工业设备、汽车、通信和计算等领域，业务覆盖全球主要市场。
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
AOSL vs APLS — 直观对比
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $162.3M | $199.9M |
| 净利润 | $-13.3M | $-59.0M |
| 毛利率 | 21.5% | — |
| 营业利润率 | -8.4% | -25.6% |
| 净利率 | -8.2% | -29.5% |
| 营收同比 | -6.3% | -5.9% |
| 净利润同比 | -101.0% | -62.2% |
| 每股收益（稀释后） | $-0.45 | $-0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $162.3M | $199.9M | ||
| Q3 25 | $182.5M | $458.6M | ||
| Q2 25 | $176.5M | $178.5M | ||
| Q1 25 | $164.6M | $166.8M | ||
| Q4 24 | $173.2M | $212.5M | ||
| Q3 24 | $181.9M | $196.8M | ||
| Q2 24 | $161.3M | $199.7M | ||
| Q1 24 | $150.1M | $172.3M |
| Q4 25 | $-13.3M | $-59.0M | ||
| Q3 25 | $-2.1M | $215.7M | ||
| Q2 25 | $-77.1M | $-42.2M | ||
| Q1 25 | $-10.8M | $-92.2M | ||
| Q4 24 | $-6.6M | $-36.4M | ||
| Q3 24 | $-2.5M | $-57.4M | ||
| Q2 24 | $-2.7M | $-37.7M | ||
| Q1 24 | $-11.2M | $-66.4M |
| Q4 25 | 21.5% | — | ||
| Q3 25 | 23.5% | — | ||
| Q2 25 | 23.4% | — | ||
| Q1 25 | 21.4% | — | ||
| Q4 24 | 23.1% | — | ||
| Q3 24 | 24.5% | — | ||
| Q2 24 | 25.7% | — | ||
| Q1 24 | 23.7% | — |
| Q4 25 | -8.4% | -25.6% | ||
| Q3 25 | -2.5% | 48.7% | ||
| Q2 25 | -6.6% | -18.6% | ||
| Q1 25 | -6.5% | -50.0% | ||
| Q4 24 | -3.4% | -12.3% | ||
| Q3 24 | -0.1% | -24.0% | ||
| Q2 24 | -0.9% | -14.7% | ||
| Q1 24 | -7.0% | -36.0% |
| Q4 25 | -8.2% | -29.5% | ||
| Q3 25 | -1.2% | 47.0% | ||
| Q2 25 | -43.7% | -23.6% | ||
| Q1 25 | -6.6% | -55.3% | ||
| Q4 24 | -3.8% | -17.1% | ||
| Q3 24 | -1.4% | -29.2% | ||
| Q2 24 | -1.7% | -18.9% | ||
| Q1 24 | -7.5% | -38.5% |
| Q4 25 | $-0.45 | $-0.40 | ||
| Q3 25 | $-0.07 | $1.67 | ||
| Q2 25 | $-2.61 | $-0.33 | ||
| Q1 25 | $-0.37 | $-0.74 | ||
| Q4 24 | $-0.23 | $-0.30 | ||
| Q3 24 | $-0.09 | $-0.46 | ||
| Q2 24 | $-0.09 | $-0.30 | ||
| Q1 24 | $-0.39 | $-0.54 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $196.3M | $466.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $818.8M | $370.1M |
| 总资产 | $1.0B | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $196.3M | $466.2M | ||
| Q3 25 | $223.5M | $479.2M | ||
| Q2 25 | $153.1M | $370.0M | ||
| Q1 25 | $169.4M | $358.4M | ||
| Q4 24 | $182.6M | $411.3M | ||
| Q3 24 | $176.0M | $396.9M | ||
| Q2 24 | $175.1M | $360.1M | ||
| Q1 24 | $174.4M | $325.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $14.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $26.7M | — | ||
| Q1 24 | — | $93.1M |
| Q4 25 | $818.8M | $370.1M | ||
| Q3 25 | $834.1M | $401.2M | ||
| Q2 25 | $822.3M | $156.3M | ||
| Q1 25 | $886.3M | $164.2M | ||
| Q4 24 | $902.6M | $228.5M | ||
| Q3 24 | $895.3M | $237.1M | ||
| Q2 24 | $891.6M | $264.3M | ||
| Q1 24 | $888.9M | $266.7M |
| Q4 25 | $1.0B | $1.1B | ||
| Q3 25 | $1.0B | $1.1B | ||
| Q2 25 | $1.0B | $821.4M | ||
| Q1 25 | $1.1B | $807.3M | ||
| Q4 24 | $1.1B | $885.1M | ||
| Q3 24 | $1.1B | $901.9M | ||
| Q2 24 | $1.1B | $904.5M | ||
| Q1 24 | $1.2B | $831.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | — | 0.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.1M | $-14.2M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-14.3M |
| 自由现金流率自由现金流/营收 | -14.2% | -7.1% |
| 资本支出强度资本支出/营收 | 9.2% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-40.9M | $45.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-8.1M | $-14.2M | ||
| Q3 25 | $10.2M | $108.5M | ||
| Q2 25 | $-2.8M | $4.4M | ||
| Q1 25 | $7.4M | $-53.4M | ||
| Q4 24 | $14.1M | $19.4M | ||
| Q3 24 | $11.0M | $34.1M | ||
| Q2 24 | $7.1M | $-8.3M | ||
| Q1 24 | $28.2M | $-133.0M |
| Q4 25 | $-23.1M | $-14.3M | ||
| Q3 25 | $420.0K | $108.3M | ||
| Q2 25 | $-17.2M | $4.4M | ||
| Q1 25 | $-1.1M | $-53.4M | ||
| Q4 24 | $6.6M | $19.3M | ||
| Q3 24 | $4.1M | — | ||
| Q2 24 | $-210.0K | $-8.4M | ||
| Q1 24 | $20.5M | $-133.3M |
| Q4 25 | -14.2% | -7.1% | ||
| Q3 25 | 0.2% | 23.6% | ||
| Q2 25 | -9.7% | 2.5% | ||
| Q1 25 | -0.6% | -32.0% | ||
| Q4 24 | 3.8% | 9.1% | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | -0.1% | -4.2% | ||
| Q1 24 | 13.7% | -77.3% |
| Q4 25 | 9.2% | 0.1% | ||
| Q3 25 | 5.4% | 0.0% | ||
| Q2 25 | 8.1% | 0.0% | ||
| Q1 25 | 5.1% | 0.0% | ||
| Q4 24 | 4.3% | 0.0% | ||
| Q3 24 | 3.8% | 0.0% | ||
| Q2 24 | 4.5% | 0.0% | ||
| Q1 24 | 5.2% | 0.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AOSL
| Power Discrete | $101.0M | 62% |
| Power Ic | $58.8M | 36% |
| Packaging And Testing Services | $2.5M | 2% |
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
